CASP3 and liver cancer: Intravenous injection of CT Casp-3 Salmonella reduced the growth of BNL-MEA tumors by 47 and 57% compared to saline and Sorafenib (P < 0.05, Fig. 7h), which is the standard-of-care for liver cancer.